Zhuhai Rundu Pharmaceutical Co Ltd Class A (002923.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE1000033G8

Price
9.01 CNY
Market cap
3.02 bn CNY
P/E (2025)
–
P/S (2025)
2.57
Dividend yield
0.00 %
Net margin
-5.40 %
Return on equity (ROE)
-6.11 %
Return on assets (ROA)
-3.13 %

Zhuhai Rundu Pharmaceutical Co Ltd Class A financials

Fiscal year20242025
Revenue1.18 bn CNY1.18 bn CNY
Gross profit490.47 m CNY454.19 m CNY
Operating income44.09 m CNY21.99 m CNY
EBIT60.06 m CNY-46.48 m CNY
Net income39.88 m CNY-63.47 m CNY
Diluted EPS – continuing operations0.12 CNY-0.19 CNY

Full history since 2011, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Zhuhai Rundu Pharmaceutical Co Ltd Class A

Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular, gastrointestinal, antibiotics, analgetic and antipyretics, anti-virus, endocrinology, and respiratory; and pellets for excipient, antiulcerative, diabetes drug, anti-inflammatory, and anti-anginals. The company is also involved in the process development, quality research, and registration of chemical drugs. In addition, it provides branding services of drug products, as well as academic services. The company was founded in 1999 and is headquartered in Zhuhai, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.